02:52:33 EDT Mon 05 Jun 2023
Enter Symbol
or Name

Integra LifeSciences Announces Participation in Upcoming Investor Conferences

2022-08-23 12:00 ET - News Release

PRINCETON, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences:

  • On September 7, 2022, Jan De Witte, chief executive officer will present at the Wells Fargo 2022 Healthcare Conference in Boston, MA at 8:35am ET.
  • On September 12, 2022, Carrie Anderson, executive vice president and chief financial officer will present at the Morgan Stanley Annual Global Healthcare Conference in New York, NY at 11:05am ET.

Webcast information can be found on the Company's website at Investor Relations.

About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel(TM), Aurora(TM), Bactiseal(TM), BioD(TM), CerebroFlo(TM), CereLink(TM) Certas(TM) Plus, Codman(TM), CUSA(TM), Cytal(TM), DuraGen(TM), DuraSeal(TM), Gentrix(TM), ICP Express(TM), Integra(TM), Licox(TM) , MAYFIELD(TM), MediHoney(TM), MicroFrance(TM), MicroMatrix(TM), NeuraGen(TM) , NeuraWrap(TM) , PriMatrix(TM), SurgiMend(TM), TCC-EZ(TM) and VersaTru(TM). For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736

Media Contact:
Laurene Isip
(609) 208-8121

© 2023 Canjex Publishing Ltd. All rights reserved.